Esodise-DSR Capsule is a combination pharmaceutical formulation containing Domperidone 30 mg and Esomeprazole 40 mg, designed for the effective management of gastroesophageal reflux disease (GERD), acid peptic disorders, and related gastrointestinal conditions. Domperidone, a peripheral dopamine D2 receptor antagonist, facilitates gastric motility and accelerates gastric emptying, thereby reducing symptoms such as nausea, vomiting, and bloating. Esomeprazole, a proton pump inhibitor (PPI), suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in gastric parietal cells, promoting mucosal healing and symptom relief in acid-related disorders. The synergistic action of these two agents provides comprehensive symptomatic relief by addressing both acid hypersecretion and impaired gastric motility. Esodise-DSR Capsule is indicated for patients experiencing frequent heartburn, acid reflux, and delayed gastric emptying. It is generally well tolerated; however, caution is advised in patients with known hypersensitivity to either component, severe hepatic impairment, or underlying cardiac conditions. Administration should follow medical guidance, considering potential drug interactions and contraindications. Regular monitoring is recommended during prolonged therapy to assess efficacy and detect any adverse effects. This combination therapy offers an effective approach to managing complex gastrointestinal symptoms, improving patient quality of life.